IMMUNOCYT 1 : A NEW TOOL FOR DETECTING TRANSITIONAL CELL CANCER OF THE URINARY TRACT
- 1 May 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 161 (5) , 1486-1489
- https://doi.org/10.1016/s0022-5347(05)68934-3
Abstract
Purpose: The limitations of cytology and the invasiveness of cystoscopy for detecting bladder cancer generate increasing interest in noninvasive, urine bound diagnostic tools. We assessed t...Keywords
This publication has 9 references indexed in Scilit:
- CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?Journal of Urology, 1998
- Improved detection of recurrent bladder cancer using the bard bta stat testUrology, 1997
- Clinical Evaluation of Nuclear Matrix Protein 22 (NMP22) in Urine as a Novel Marker for Urothelial CancerEuropean Urology, 1997
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- MAUB Is a New Mucin Antigen Associated with Bladder CancerPublished by Elsevier ,1996
- Monoclonal antibodies in bladder cancer cytologyWorld Journal of Urology, 1991
- Monoclonal antibody against a tumor‐associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomasInternational Journal of Cancer, 1990
- Clinical Evaluation of Urinary and Serum Carcinoembryonic Antigen in Bladder CancerJournal of Urology, 1975